Delivery Order SPE2DB20D1100-SPE2DB25FD8X7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Linzess 290 microgram capsules (30-count unit) valued at $1,153.75, with performance based in Conshohocken, Pennsylvania. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,072.79 to supply Linzess 290 microgram capsules (30-count units) under a firm fixed price contract. The delivery order, issued September 5, 2025, with an ultimate completion date of September 8, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,423.44 to supply Linzess 72 microgram capsules (30-count units) under a firm fixed price contract. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive, non-set-aside delivery order. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,321.41 to AmerisourceBergen Drug Corp for the supply of Linzess 290 micrograms capsules (30-count units). This competitively awarded, firm fixed-price delivery order was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract represents a small-value pharmaceutical supply transaction fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,982.88 by the Defense Logistics Agency (DLA) on April 25, 2025, with an ultimate completion date of April 28, 2025. The contract, awarded without set-aside designation through competitive procurement, calls for the delivery of Linzess 145 micrograms capsules in a 30-count unit. This delivery order operates under a firm fixed-price structure and represents...
- The Defense Logistics Agency awarded a delivery order valued at $8,164.40 to AmerisourceBergen Drug Corp for Linzess 290 microgram capsules (30-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of LINZESS 290mg capsules in a 30-count package. The contract carries a ceiling value of $1,102.95 and utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performance location for this order. This delivery order is issued under a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,247.40 to AmerisourceBergen Drug Corp for Linzess 145 microgram capsules (30-count units) under a firm fixed-price contract. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a competitive award to the prime contractor, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,064.49 to AmerisourceBergen Drug Corp for Linzess 290 microgram capsules (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp for Linzess 72 microgram capsules (30-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8X7Delivery Order
The Defense Logistics Agency awarded a $3,795.86 delivery order to AmerisourceBergen Drug Corp for LINZESS 290 microgram capsules (30-count units) on August 6, 2025, with ultimate completion by August 7, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies delivered through competitively awarded contracts with the Defense Logistics Agency, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, and specialty medical supplies. The DLA Troop Support Medical contract enables AmerisourceBergen to supply military healthcare programs worldwide and serve additional government customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/6/25 |